Skip to product information
1 of 1

Invivo anti-mouse CD40L (CD154) Recombinant mAb

Invivo anti-mouse CD40L (CD154) Recombinant mAb

Catalog Number: S0B0691 Application: ELISA,Functional/Block/Neutralize Reactivity: Mouse Conjugation: Unconjugated Brand: Starter
Price:
Regular price $200.00 USD
Regular price Sale price $200.00 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Armenian hamster
Synonyms CD40 ligand, CD40-L, T-cell antigen Gp39, TNF-related activation protein (TRAP), Tumor necrosis factor ligand superfamily member 5, CD154, Cd40lg, Cd40l, Tnfsf5
Accession P27548
Clone Number MR-1
Antibody Type Armenian hamster mAb
Isotype Armenian Hamster IgG1
Application ELISA, in vivo blocking of CD40/CD40L signaling, in vitro blocking of CD40/CD40L signaling
Reactivity Ms
Purification Protein G
Concentration 5 mg/ml
Purity >95% Determined by SDS-PAGE
Endotoxin <2EU/mg
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer PBS pH7.4, containing no preservative
Stability & Storage

2 to 8 °C for 2 weeks under sterile conditions;

-20 °C for 3 months under sterile conditions; 

-80 °C for 24 months under sterile conditions.

Please avoid repeated freeze-thaw cycles.

Background

CD40L, also known as gp39, tumor necrosis factor-related activation protein (TRAP), or T cell-B cell activating molecule (T-BAM), is a 33-kDa type II transmembrane glycoprotein consisting of 266 amino acids. It has a 214-amino acid extracellular domain that shares a high degree of homology with tumor necrosis factor (TNF) at the amino acid level. The primary function of CD40L is to participate in immune responses by binding to CD40, a molecule widely expressed on immune cells. The CD40-CD40L interaction activates various signaling pathways, regulating a broad range of cellular responses, including proliferation, differentiation, and cell death. Additionally, CD40L expression is typically inducible and primarily found on activated CD4+ T lymphocytes, with partial expression on activated CD8+ T cells, basophils, mast cells, and NK cells.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)